Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/VAXXINITY-INC-129226100/news/Vaxxinity-Announces-Positive-Target-Engagement-Data-from-Phase-1-Clinical-Trial-for-Parkinson-s-Dise-46125221/?utm_source=whatsapp&utm_medium=social&utm_campaign=share